WO2005112755A3 - Morphometric analysis of brain structures - Google Patents

Morphometric analysis of brain structures Download PDF

Info

Publication number
WO2005112755A3
WO2005112755A3 PCT/US2005/018153 US2005018153W WO2005112755A3 WO 2005112755 A3 WO2005112755 A3 WO 2005112755A3 US 2005018153 W US2005018153 W US 2005018153W WO 2005112755 A3 WO2005112755 A3 WO 2005112755A3
Authority
WO
WIPO (PCT)
Prior art keywords
brain structures
morphometric analysis
disorder
abnormal behavior
active
Prior art date
Application number
PCT/US2005/018153
Other languages
French (fr)
Other versions
WO2005112755A2 (en
Inventor
Nikolaos Makris
Gregory Gasic
Hans C Breiter
David N Kennedy
Original Assignee
Gen Hospital Corp
Nikolaos Makris
Gregory Gasic
Hans C Breiter
David N Kennedy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp, Nikolaos Makris, Gregory Gasic, Hans C Breiter, David N Kennedy filed Critical Gen Hospital Corp
Publication of WO2005112755A2 publication Critical patent/WO2005112755A2/en
Publication of WO2005112755A3 publication Critical patent/WO2005112755A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves 
    • A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves  involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/40—Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4058—Detecting, measuring or recording for evaluating the nervous system for evaluating the central nervous system
    • A61B5/4064—Evaluating the brain

Abstract

Morphometric information about brain structures can be used as an indicator of resistance/susceptibility to a disorder or abnormal behavior, therapeutic efficacy, and the presence and staging of active illness (e.g., an active disorder or abnormal behavior). For example, topological analysis of iso-surfaces from the amygdala can be used to identify cocaine-dependency.
PCT/US2005/018153 2004-05-21 2005-05-23 Morphometric analysis of brain structures WO2005112755A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US57313804P 2004-05-21 2004-05-21
US60/573,138 2004-05-21
US59850304P 2004-08-02 2004-08-02
US60/598,503 2004-08-02

Publications (2)

Publication Number Publication Date
WO2005112755A2 WO2005112755A2 (en) 2005-12-01
WO2005112755A3 true WO2005112755A3 (en) 2006-01-12

Family

ID=35428799

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/018153 WO2005112755A2 (en) 2004-05-21 2005-05-23 Morphometric analysis of brain structures

Country Status (1)

Country Link
WO (1) WO2005112755A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110288590B (en) * 2019-07-01 2023-05-16 兰州大学 Morphological measurement-based method for positioning vulnerable area of depression subcortical structure
CN112820396B (en) * 2020-12-30 2023-10-17 电子科技大学 Automatic diagnosis device for realizing depression based on network fragility
CN113780394B (en) * 2021-08-31 2023-05-09 厦门理工学院 Training method, device and equipment for strong classifier model
CN113724784B (en) * 2021-09-08 2022-05-06 山东建筑大学 System and method for drawing asymmetric genetic structure of Alzheimer's disease semi-brain
CN116681705B (en) * 2023-08-04 2023-09-29 哈尔滨工业大学(深圳)(哈尔滨工业大学深圳科技创新研究院) Surface morphology measurement method and processing equipment based on longitudinal structure of human brain hippocampus

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6415048B1 (en) * 1993-10-12 2002-07-02 Schneider Medical Technologies, Inc. Compositional analysis system
US6517812B1 (en) * 1997-09-24 2003-02-11 The General Hospital Corporation Inhibition of psychostimulant-induced and nicotine-induced craving
US20040015076A1 (en) * 2000-11-27 2004-01-22 Taiju Matsuzawa Method and apparatus for taking cerebral laminograms for working up limbic system
US6731782B2 (en) * 2002-10-02 2004-05-04 Virtualscopics, Llc Method and system for automatic identification and quantification of abnormal anatomical structures in medical images

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6415048B1 (en) * 1993-10-12 2002-07-02 Schneider Medical Technologies, Inc. Compositional analysis system
US6517812B1 (en) * 1997-09-24 2003-02-11 The General Hospital Corporation Inhibition of psychostimulant-induced and nicotine-induced craving
US20040029872A1 (en) * 1997-09-24 2004-02-12 The General Hospital Corporation, A Massachusetts Corporation Inhibition of psychostimulant-induced and nicotine-induced craving
US20040015076A1 (en) * 2000-11-27 2004-01-22 Taiju Matsuzawa Method and apparatus for taking cerebral laminograms for working up limbic system
US6731782B2 (en) * 2002-10-02 2004-05-04 Virtualscopics, Llc Method and system for automatic identification and quantification of abnormal anatomical structures in medical images

Also Published As

Publication number Publication date
WO2005112755A2 (en) 2005-12-01

Similar Documents

Publication Publication Date Title
WO2008003049A3 (en) Distinguishing different drug effects from the electroencephalogram
WO2007038587A3 (en) Company and contact information system and method
ATE322038T1 (en) METHOD AND SYSTEM FOR FIGHTING ROBOTS AND ROGUES
EP1755448A4 (en) Systems and methods for detecting deception by measuring brain activity
EP1744708A4 (en) Devices, systems and methods for diagnosing and treating sinusitus and other disorders of the ears, nose and/or throat
WO2007120480A3 (en) Systems and methods for predicting effectiveness in the treatment of psychiatric disorders, including depression
WO2007021496A3 (en) Systems and methods for improved health care compliance
WO2005112755A3 (en) Morphometric analysis of brain structures
WO2007072225A8 (en) Methods and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy
WO2006084131A3 (en) Furin inhibitors and alpha-defensins for the treatment or prevention of papillomavirus infection
WO2008063382A3 (en) Antagonists of pcsk9
WO2008133647A3 (en) Antagonists of pcsk9
WO2007061755A3 (en) Systems and methods to assess one or more body fluid metrics
WO2006136174A3 (en) Methods and systems for assessing hearing ability
WO2006131599A3 (en) Method of profiling a cell population
WO2009004403A3 (en) Burst suppression monitor for induced coma
WO2006071812A3 (en) Platinum iv complex inhibitor
WO2003013343A3 (en) Method for psychophysiological detection of deception through brain function analysis
WO2007119179A3 (en) Use of the ornithine transcarbamylase (otc), as a marker for diagnosing brain damages
WO2007022208A3 (en) Neuronal avalanche assay
WO2006074450A3 (en) Methods and compositions for detecting and modulating periodontal disorders and periodontal diseases
WO2011072007A3 (en) Methods and compositions for detection and identification of organophosphorus nerve agents, pesticides and other toxins
WO2008024483A3 (en) Array-based analyte detection
WO2005092924A8 (en) Rab9a, rab11a, and modulators thereof related to infectious disease
WO2014100602A8 (en) Treatment of egf-receptor dependent pathologies

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase